Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy

被引:20
|
作者
Diedrich, Chantal M. [1 ]
Kastelein, Arnoud W. [1 ]
Verri, Filippo M. [1 ]
Weber, Maaike A. [1 ]
Ince, Can [2 ,3 ]
Roovers, Jan-Paul W. R. [1 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam UMC, Dept Translat Physiol, Amsterdam, Netherlands
[3] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands
关键词
estrogen; imaging; microcirculation; vulvovaginal atrophy;
D O I
10.1002/nau.23977
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims This study aims to assess vaginal wall angioarchitecture and function in women with vulvovaginal atrophy (VVA) and determine the effect of topical estrogen on the vaginal microcirculation. Materials and Methods In this prospective observational study, incident dark field imaging was used to assess the vaginal microcirculation. In patients with VVA, measurements were performed before and after treatment with topical estrogen and compared to measurements performed in women without VVA. Vaginal angioarchitecture was studied by assessing microcirculatory architecture and capillary tortuosity scores at four regions of the vaginal wall. In addition, the capillary density and microvascular flow index (MFI) were obtained. Results Seventeen women were included in this study. Of these, eight women were diagnosed with VVA and nine women were considered healthy controls. Significant differences were observed between groups with regard to microcirculatory architecture scores. The architecture of the microvasculature in women with VVA was characterized by the appearance of a vascular network without capillary loops, whereas an array of capillary loops was predominantly seen in women without VVA. After estrogen treatment, no difference in architecture scores between patients and healthy controls was observed. Capillary tortuosity, capillary density, and MFI were similar in both groups before and after estrogen treatment. Conclusions The architecture of vaginal microvasculature is altered in patients with VVA. In case of similar vascular architecture, capillary tortuosity and density seem to be comparable. Treatment with topical estrogen results in restoration of the angioarchitecture.
引用
收藏
页码:1298 / 1304
页数:7
相关论文
共 50 条
  • [41] Vaginal allergic response in women with vulvovaginal candidiasis
    Fan, S. R.
    Liao, Q. P.
    Liu, X. P.
    Liu, Z. H.
    Zhang, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 101 (01) : 27 - 30
  • [42] Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy
    Chism, Lisa A.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 : 551 - 557
  • [43] Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
    Parish, Sharon J.
    Nappi, Rossella E.
    Krychman, Michael L.
    Kellogg-Spadt, Susan
    Simon, James A.
    Goldstein, Jeffrey A.
    Kingsberg, Sheryl A.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 437 - 447
  • [44] Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?
    Ewies, A. A. A.
    Alfhaily, F.
    CLIMACTERIC, 2010, 13 (05) : 405 - 418
  • [45] Vaginal estrogen preparations: A review of safety and efficacy for vaginal atrophy
    Crandall, C
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (10): : 857 - 877
  • [46] Effect of Vaginal Laser and Topical Therapies on Vulvovaginal Atrophy Symptoms in Breast Cancer Patients: A Systematic Review and Meta-Analysis
    Loczi, Lotti Lucia
    Vlesko, Gabor
    Elias, Mate
    Turan, Caner
    Kajtar, Panna
    Toth, Reka
    Sipos, Miklos
    Nagy, Rita
    Hegyi, Peter
    Acs, Nandor
    Varbiro, Szabolcs
    Keszthelyi, Marton
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [47] Vaginal estrogen therapy
    Schueler-Toprak, Susanne
    Ortmann, Olaf
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2022, 20 (03): : 197 - 200
  • [48] Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial
    Torky, H. A.
    Taha, A.
    Marie, H.
    El-Desouky, E.
    Raslan, O.
    Moussa, A. A.
    Ahmad, A. M.
    Abo-Louz, A.
    Zaki, S.
    Fares, T.
    Eesa, A.
    CLIMACTERIC, 2018, 21 (02) : 174 - 178
  • [49] Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy
    Brotman, Rebecca M.
    Shardell, Michelle D.
    Gajer, Pawel
    Fadrosh, Doug
    Chang, Kathryn
    Silver, Michelle I.
    Viscidi, Raphael P.
    Burke, Anne E.
    Ravel, Jacques
    Gravitt, Patti E.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (05): : 450 - 458
  • [50] Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study
    Pearson, Antonia
    Booker, Andrew
    Tio, Martin
    Marx, Gavin
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) : 135 - 140